Form 8-K - Current report:
SEC Accession No. 0001728117-25-000022
Filing Date
2025-03-13
Accepted
2025-03-13 16:02:11
Documents
15
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20250313.htm   iXBRL 8-K 31278
2 EX-99.1 goss-20250313xexx991.htm EX-99.1 71195
6 GRAPHIC gosslogo.jpg GRAPHIC 3035
  Complete submission text file 0001728117-25-000022.txt   238796

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250313.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250313_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250313_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250313_htm.xml XML 3015
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 25735642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)